Strategy | Financing Transactions Private Placement / Financing Transactions Nura Bio: The company raised $141 million of Series A venture funding in a deal led by The Column Group on September 17, 2024, putting the company’s pre-money valuation at $35 million....
Strategy | Financing Transactions Private Placement / Financing Transactions Pantera: The company raised EUR 134 million of Series A venture funding on September 11, 2024, putting the company’s pre-money valuation at EUR 179.8 million. The company is an operator...
Strategy | Financing Transactions Private Placement / Financing Transactions Egenesis: The company raised $191 million of Series D venture funding in a deal led by Lux Capital on September 4, 2024. Fresenius Medical Care Ventures, Leaps by Bayer, DaVita, Eisai...
Strategy | Financing Transactions Private Placement / Financing Transactions Navigator Medicines: The company raised $100 million of Series A venture funding in a deal led by RA Capital Management and Forbion on August 27, 2024, putting the company’s pre-money...
Strategy | Financing Transactions Private Placement / Financing Transactions Borealis Biosciences: The company raised $150 million of Series A venture funding from Novartis and Versant Ventures on August 22, 2024. The company is an operator of a discovery-stage...
Strategy | Financing Transactions Private Placement / Financing Transactions Caresyntax: The company raised $180 million of funding through a combination of debt and equity on August 15, 2024. $80 million of Series C venture funding was provided by Blackrock...
